Skip to main content
. 2020 Dec 13:1–16. doi: 10.1080/03007995.2020.1853508

Table 1.

The demographic and clinical characteristics of patients with COVID-19.

  Total (n = 317) Survival (n = 269) Dead (n = 48) p-Value
Demographic information        
 Age, year 59 (49–67) 57 (47–66) 66 (61–71) <.001
 Age groups       <.001
  <65 223 (70.3) 200 (74.3) 23 (47.9)  
  ≥65 94 (29.7) 69 (25.7) 25 (52.1)  
 Sex       .044
  Female 148 (46.7) 16 (33.3) 132 (49.1)  
  Male 169 (53.3) 32 (66.7) 137 (50.9)  
Chronic medical histories 147 (46.4) 121 (45.0) 26 (54.2) .24
 Chronic pulmonary disease 23 (7.3) 15 (5.6) 8 (16.7) .006
 Coronary heart disease 24 (7.6) 21 (7.8) 3 (6.3) .707
 Hypertensive heart disease 85 (26.8) 68 (25.3) 17 (35.4) .144
 Stroke 4 (1.3) 4 (1.5) 0 (0) .395
 Diabetes 42 (13.2) 35 (13.0) 7 (14.6) .767
Symptoms        
 Fever 256 (80.8) 216 (80.3) 40 (83.3) .623
 Coughing and sputum 206 (65.0) 168 (62.5) 38 (79.2) .025
 Shortness of breath 146 (46.1) 116 (43.1) 30 (62.5) .013
 Gastrointestinal symptoms 186 (52.7) 154 (57.2) 32 (66.7) .222

Note. Continuous variables were expressed as median (P25–P75); categorical variables were expressed as number (%).

Abbreviation. P25–P75, percentile 25 to percentile 75.

Statistically significant differences between groups are marked in bold.